Similarly, Wang et al. indicated that TRIM21 accelerated the progression of HCC by inhibiting the anti-antioxidant signaling of p62-Keap1-Nrf2 in vivo mice model [34]. This evidence concerns the gene TRIM21 and hepatocellular carcinoma.